For the annual performance in FY24, HCG's revenue was Rs 19,121 million
Read More
On an yearly basis, gross profit for FY24 was Rs16,291 million, up 22 per cent from Rs 13,328 million in FY23
Read More
In Q4 FY24, JB Pharma recorded a revenue of Rs 862 crores, marking a 13 per cent increase from Rs 762 crores in Q4 FY23
Read More
In Q4 FY24, Mankind Pharma reported revenue from operations of Rs 2,441 Cr, marking a notable 19 per cent year-on-year (YoY) increase
Read More
